SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024711
Filing Date
2024-10-03
Accepted
2024-10-03 21:22:40
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10042024_011036.html 4  
1 form4-10042024_011036.xml 4 6973
  Complete submission text file 0001415889-24-024711.txt   8503
Mailing Address 4955 BASELINE AVENUE SANTA YNEZ CA 93460
Business Address
Gangolli Julian S (Reporting) CIK: 0001532023 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 241353327

Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)